deltatrials
Completed PHASE3 INTERVENTIONAL 4-arm NCT03248128

Safety and Efficacy Study of Fluticasone Furoate/Vilanterol (FF/VI) Fixed Dose Combination (FDC) Compared to FF Alone in Subjects With Asthma

A Randomised, Double-blind, Parallel Group, Multicentre, Stratified, Study Evaluating the Efficacy and Safety of Once Daily Fluticasone Furoate/Vilanterol Inhalation Powder Compared to Once Daily Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Participants Aged 5 to 17 Years Old (Inclusive) Currently Uncontrolled on Inhaled Corticosteroids

Sponsor: GlaxoSmithKline

Conditions Asthma
Interventions FF via ELLIPTA DPI FF/VI via ELLIPTA DPI
Updated 32 times since 2017 Last updated: Jun 4, 2025 Started: Oct 20, 2017 Primary completion: Mar 21, 2022 Completion: Mar 21, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Asthma, this trial is completed. The trial is conducted by GlaxoSmithKline and has accumulated 32 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Sep 2017 – ~Nov 2017 · 2 months · monthly snapshot~Nov 2017 – ~Mar 2018 · 4 months · monthly snapshot~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshot~Oct 2018 – ~Nov 2018 · 31 days · monthly snapshot~Nov 2018 – ~Jul 2019 · 8 months · monthly snapshot~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Sep 2019 · 31 days · monthly snapshot~Sep 2019 – ~Oct 2019 · 30 days · monthly snapshot~Oct 2019 – ~Dec 2019 · 2 months · monthly snapshot~Dec 2019 – ~Mar 2020 · 3 months · monthly snapshot~Mar 2020 – ~Apr 2020 · 31 days · monthly snapshot~Apr 2020 – ~Oct 2020 · 6 months · monthly snapshot~Oct 2020 – ~Nov 2020 · 31 days · monthly snapshot~Nov 2020 – ~Dec 2020 · 30 days · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Mar 2021 · 28 days · monthly snapshot~Mar 2021 – ~Nov 2021 · 8 months · monthly snapshot~Nov 2021 – ~Jun 2022 · 7 months · monthly snapshot~Jun 2022 – ~Nov 2022 · 5 months · monthly snapshot~Nov 2022 – ~Jun 2023 · 7 months · monthly snapshot~Jun 2023 – ~Jul 2024 · 13 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jul 2025 · 10 months · monthly snapshot~Jul 2025 – ~Sep 2025 · 2 months · monthly snapshot~Sep 2025 – present · 12 months · monthly snapshot

Change History

32 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Jul 2025 — Sep 2025 [monthly]

    Completed PHASE3

  3. Sep 2024 — Jul 2025 [monthly]

    Completed PHASE3

  4. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  5. Jun 2023 — Jul 2024 [monthly]

    Completed PHASE3

▶ Show 27 earlier versions

  1. Nov 2022 — Jun 2023 [monthly]

    Completed PHASE3

  2. Jun 2022 — Nov 2022 [monthly]

    Completed PHASE3

    Status: Recruiting → Completed

  3. Nov 2021 — Jun 2022 [monthly]

    Recruiting PHASE3

  4. Mar 2021 — Nov 2021 [monthly]

    Recruiting PHASE3

  5. Feb 2021 — Mar 2021 [monthly]

    Recruiting PHASE3

  6. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE3

  7. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE3

  8. Nov 2020 — Dec 2020 [monthly]

    Recruiting PHASE3

  9. Oct 2020 — Nov 2020 [monthly]

    Recruiting PHASE3

  10. Apr 2020 — Oct 2020 [monthly]

    Recruiting PHASE3

  11. Mar 2020 — Apr 2020 [monthly]

    Recruiting PHASE3

  12. Dec 2019 — Mar 2020 [monthly]

    Recruiting PHASE3

  13. Oct 2019 — Dec 2019 [monthly]

    Recruiting PHASE3

  14. Sep 2019 — Oct 2019 [monthly]

    Recruiting PHASE3

  15. Aug 2019 — Sep 2019 [monthly]

    Recruiting PHASE3

  16. Jul 2019 — Aug 2019 [monthly]

    Recruiting PHASE3

  17. Nov 2018 — Jul 2019 [monthly]

    Recruiting PHASE3

  18. Oct 2018 — Nov 2018 [monthly]

    Recruiting PHASE3

  19. Sep 2018 — Oct 2018 [monthly]

    Recruiting PHASE3

  20. Aug 2018 — Sep 2018 [monthly]

    Recruiting PHASE3

  21. Jul 2018 — Aug 2018 [monthly]

    Recruiting PHASE3

  22. Jun 2018 — Jul 2018 [monthly]

    Recruiting PHASE3

  23. May 2018 — Jun 2018 [monthly]

    Recruiting PHASE3

  24. Apr 2018 — May 2018 [monthly]

    Recruiting PHASE3

  25. Mar 2018 — Apr 2018 [monthly]

    Recruiting PHASE3

  26. Nov 2017 — Mar 2018 [monthly]

    Recruiting PHASE3

    Status: Not Yet Recruiting → Recruiting

  27. Sep 2017 — Nov 2017 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • GlaxoSmithKline
Data source: GlaxoSmithKline

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ancona, Italy , Asheville, United States , Aventura, United States , Badalona, Spain , Baltimore, United States , Barcelona, Spain , Bellville, South Africa , Berazategui, Argentina , Bergamo, Italy , Bialystok, Poland and 128 more locations